BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 6818095)

  • 1. [Comparative sonographic and endocrine studies of gonadotropin-stimulated menstrual cycles].
    Geisthövel F; Skubsch U; Schillinger H; Breckwoldt M
    Geburtshilfe Frauenheilkd; 1982 Nov; 42(11):819-23. PubMed ID: 6818095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum 17beta-estradiol. Index of follicular maturation during gonadotropin therapy.
    Notation AD; Tagatz GE; Steffes MW
    Obstet Gynecol; 1978 Feb; 51(2):204-9. PubMed ID: 622235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovulation induction by human menopausal gonadotropin with ultrasonic monitoring of the ovarian follicles.
    Tulandi T; Hamilton EF; Arronet GH; Coleman PW; McInnes RA
    Int J Fertil; 1987; 32(4):312-5. PubMed ID: 2887531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing severe ovarian hyperstimulation syndrome in an in vitro fertilization/embryo transfer program. Use of follicular aspiration after human chorionic gonadotropin administration.
    Vrtovec HM; Tomazevic T
    J Reprod Med; 1995 Jan; 40(1):37-40. PubMed ID: 7722973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and biophysical indices of follicular development in spontaneous and stimulated ovulatory cycles.
    Fossum GT; Vermesh M; Kletzky OA
    Obstet Gynecol; 1990 Mar; 75(3 Pt 1):407-11. PubMed ID: 2106108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum estradiols versus pelvic sonography in monitoring HMG therapy.
    Check JH; Goldberg BB; Kurtz A; Adelson HG; Dietterich C
    Int J Fertil; 1985; 30(2):61-3. PubMed ID: 2865227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gonadotrophin induction of ovulation monitored by ultrasonic studies of the ovary].
    van Schouwenburg JA
    S Afr Med J; 1985 May; 67(19):754-8. PubMed ID: 3922064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Papanikolaou EG; Pozzobon C; Kolibianakis EM; Camus M; Tournaye H; Fatemi HM; Van Steirteghem A; Devroey P
    Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress in sterility therapy. Gonadotropin treatment, monitoring follicle maturation using real-time ultrasonics].
    Schmidt W; von Holst T
    Fortschr Med; 1981 Jul; 99(27-28):1080-6. PubMed ID: 6790397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of ovulation monitored by ultrasound.
    McArdle CR; Seibel M; Weinstein F; Hann LE; Nickerson C; Taymor ML
    Radiology; 1983 Sep; 148(3):809-12. PubMed ID: 6410452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT; Ohlinger R
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma hormones in human gonadotropin induced ovulation.
    Wu CH
    Obstet Gynecol; 1977 Mar; 49(3):308-13. PubMed ID: 840459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and endocrinologic aspects of treatment with pure FSH. A report of experiences].
    Graf M; Freundl G
    Zentralbl Gynakol; 1990; 112(2):81-90. PubMed ID: 2107649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A comparative study of monitoring induction of ovulation using clomiphene and HMG-HCG. Hormonal and ultrasound profiles (author's transl)].
    Salat-Baroux J; Uzan S; Giacomini P; Scemama H; Vuillard E; Boccara V
    J Gynecol Obstet Biol Reprod (Paris); 1981; 10(4):369-74. PubMed ID: 6795255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of ultra-short gonadotropin-releasing hormone agonist protocol in controlled ovarian hyperstimulation].
    Zhao X; Zhang L; Gong S
    Zhonghua Fu Chan Ke Za Zhi; 1997 Oct; 32(10):589-92. PubMed ID: 9642373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Continuous pulsatile subcutaneous gonadotropin stimulation in polycystic ovary syndrome: a therapeutic alternative].
    Steck T; Würfel W; Witteler M; Albert P
    Geburtshilfe Frauenheilkd; 1991 May; 51(5):373-8. PubMed ID: 1907938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian response in World Health Organization group II anovulatory women during consecutive human menopausal gonadotropin cycles.
    Fluker MR; Yarali H; Yuen BH
    J Reprod Med; 1993 Nov; 38(11):839-42. PubMed ID: 8277477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sonographic appearance of the endometrium and ovaries during cycles stimulated with human menopausal gonadotropin.
    Reuter KL; Cohen S; Furey L; Baker S
    J Reprod Med; 1996 Jul; 41(7):509-14. PubMed ID: 8829064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of ovulation induction with human menopausal gonadotropin and human chorionic gonadotropin by ultrasound.
    Cabau A; Bessis R
    Fertil Steril; 1981 Aug; 36(2):178-82. PubMed ID: 6790307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian hyperstimulation syndrome: prediction by number and size of preovulatory ovarian follicles.
    Blankstein J; Shalev J; Saadon T; Kukia EE; Rabinovici J; Pariente C; Lunenfeld B; Serr DM; Mashiach S
    Fertil Steril; 1987 Apr; 47(4):597-602. PubMed ID: 3106098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.